203
229.
Hizel S., Parker S., Onde U. Seroprevalence of cytomegalovirus infection
among children and females in Ankara, Turkey, 1995.
ff
Pediatr. Int. - 1999. -41
(5). - P. 506-509.
230.
Hoppen Т., Eis-Hubinger A.M., Scliild R.L., Enders G. et al. Intrauterine
herpes simplex virus infection,
ff
Klin. Pediatr. - 2001. - 213 (2). - P. 63-68.
231.
Hugh J. Field. Herpes simplex virus antiviral drug resistance - current
trends and future prospects. // J. Clin. Virol. - 2001. - 21 (3). - P. 261-269.
232.
Isacsolm М., Smetana Z., Rones Z.Z., Raveh D. et al. Sero-epidemiological
study of herpes vims type I and 2 infection in Israel,
ff
J. Clin. Virol. - 2002. - 24
(1-2).-P . 85-92.
233.
Joss A.W.L., Skinner L.J., Chatterton J.M.W. et al. Simultaneous
serological screening for congenital cytomegalovirus and toxoplasma infection. -
Public Health - 1988. - Vol. 102.- P. 407-417.
234.
Kashman N., Kramer U., Stavopovsky Z., Shefer-Kaufmami N. et al.
Prognostic significance of hyperechogenic lesions in the basal ganglia and
thalamus in neonates,
ff
J. Child. Neurol. - 2001. - 16 (8). - P. 591-594.
235.
Khan N.A., Kazzi S.N. Yield and costs of screening growth-retarded
infants for TORCH infections,
ff
Am. J. Perinatol. - 2000. - 17 (3). - P. 131-135.
236.
Kiezebrink-Lindenhovius H.H., van den Berg Y.L., Sprikkehnan A.L.,
Weel J.F. et al. Cytomegalovirus infection: congenital or postnatally acquired?
Importance of the Guthrie card. //Ned. Tijdschr. Geneeskd. - 2001. - 145 (26). -
P. 1259-1261.
237.
Kimberlin D.W., Lin C.Y., Jacobs R.F., Powell D.A. et al. Natural history
of neonatal herpes simplex virus infections in the acyclovir era.
ff
J. Pediatr. -
2001,- 108 (2).-P . 223-229.
238.
Kimberlin D.W., Lin C.Y., Jacobs R.F., Powell D.A. et al. Safety and
efficacy of high-dose intravenous acyclovir in the management of neonatal herpes
simplex vims infections,
ff
J. Pediatr. - 2001. - 108 (2). - P. 223-229.
